Full Text
PCV39 COST-EFFECTIVENESS OF NIASPANVERSUS ZETIA AS ADD-ON TREATMENTTO STATIN THERAPY IN HIGH-RISK PATIENTS

Abstract

Authors

SV Sorensen SF Webb RT Burge

Back to Volume 11, Issue 6
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×